KAYLIN HATFIELD: Open Payments
NPI 1225874811 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$837 in 41 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $120 · 2025 $837
Food & beverage: $837
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $243 |
| Lilly USA, LLC | 5 | $105 |
| ABBVIE INC. | 3 | $80 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $78 |
| Exact Sciences Corporation | 4 | $64 |
| Astellas Pharma US Inc | 3 | $49 |
| Phathom Pharmaceuticals, Inc. | 2 | $36 |
| SHIELD THERAPEUTICS INC | 1 | $35 |
| SANOFI-AVENTIS U.S. LLC | 1 | $24 |
| Gilead Sciences, Inc. | 1 | $24 |
Products named: AIRSUPRA, JARDIANCE, MOUNJARO, UBRELVY, Veozah, BREZTRI, FARXIGA, VOQUEZNA.
Industry payments across OK — which companies pay providers there.
